Dysfunction of Soluble Guanylyl Cyclase in Aorta and Kidney of Goto–Kakizaki Rats: Influence of Age and Diabetic State

Nitric Oxide - Tập 6 - Trang 85-95 - 2002
Klaus Witte1, Kerstin Jacke1, Raoul Stahrenberg1, Gerrit Arlt1, Ina Reitenbach1, Lothar Schilling2, Björn Lemmer1
1Institute of Pharmacology & Toxicology, Faculty of Clinical Medicine Mannheim, Ruprecht-Karls-University Heidelberg, D-68169, Mannheim, Germany
2Department of Neurosurgery, Faculty of Clinical Medicine Mannheim, Ruprecht-Karls-University Heidelberg, D-68169, Mannheim, Germany

Tài liệu tham khảo

Gress, 2000, Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus, N. Engl. J. Med., 342, 905, 10.1056/NEJM200003303421301

Johnstone, 1993, Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus, Circulation, 88, 2510, 10.1161/01.CIR.88.6.2510

Watts, 1996, Impaired endothelium-dependent and independent dilation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: Role of dyslipidaemia, Clin. Sci. (Colch.), 91, 567, 10.1042/cs0910567

Yuen, 1990, A new form of guanylyl cyclase is preferentially expressed in rat kidney, Biochemistry, 29, 10872, 10.1021/bi00501a002

Goto, 1981, The spontaneous-diabetes rat: A model of noninsulin dependent diabetes mellitus, Proc. Jpn. Acad., 57, 381, 10.2183/pjab.57.381

Portha, 1991, Beta-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes, Diabetes, 40, 486, 10.2337/diab.40.4.486

Farese, 1994, Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto–Kakizaki rats, Proc. Natl. Acad. Sci. USA, 91, 11040, 10.1073/pnas.91.23.11040

Valensi, 1996, Rhéologie érythrocytaire et hypertrophie cardiaque au cours du diabète sucré, J. Mal. Vasc., 21, 185

Yamashita, 1996, Insulin resistance and body fat distribution, Diabetes Care, 19, 287, 10.2337/diacare.19.3.287

Witte, 1995, Contribution of the nitric oxide–guanylyl cyclase system to circadian regulation of blood pressure in normotensive Wistar–Kyoto rats, Cardiovasc. Res., 30, 682, 10.1016/0008-6363(95)00072-0

Ignarro, 1987, Activation of purified guanylate cyclase by arachidonic acid requires absence of enzyme-bound heme, Biochim. Biophys. Acta, 928, 160, 10.1016/0167-4889(87)90117-0

Lemmer, 1993, Circadian blood pressure variation in transgenic hypertensive rats, Hypertension, 22, 97, 10.1161/01.HYP.22.1.97

Mattes, 1991, Pharmfit—A nonlinear fitting program for pharmacology, Chronobiol. Int., 8, 460, 10.3109/07420529109059182

Ackermann, 1997

De Vriese, 2000, Endothelial dysfunction in diabetes, Br. J. Pharmacol., 130, 963, 10.1038/sj.bjp.0703393

Wedel, 1994, Mutation of His-105 in the β1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase, Proc. Natl. Acad. Sci. USA, 91, 2592, 10.1073/pnas.91.7.2592

Friebe, 1997, Functions of conserved cysteines of soluble guanylyl cyclase, Biochemistry, 36, 1194, 10.1021/bi962047w

Nishikawa, 2000, Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, Nature, 404, 787, 10.1038/35008121

Gupta, 1997, The β2 subunit inhibits stimulation of the α1/β1 form of soluble guanylyl cyclase by nitric oxide, J. Clin. Invest., 100, 1488, 10.1172/JCI119670

Phillips, 2001, Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the Goto Kakizaki model of non-insulin-dependent diabetes mellitus, Am. J. Kidney Dis., 37, 400, 10.1053/ajkd.2001.21322